BeiGene has settled a lawsuit with generics manufacturer MSN Pharmaceuticals, resolving all cases associated with the entry of Brukinsa alternatives in the US.
The pharma …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Gabe Canales’ experience with low-risk prostate cancer nearly matches mine — with a couple of caveats, including a 27-year difference in the ages at which
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
PHILADELPHIA — A novel, plant-based oral estrogen improved metabolic profiles while also quelling menopause-related vasomotor symptoms, secondary outcomes from the phase III E4 Comfort I